Abstract Background Several studies have confirmed that mobilizing bone marrow-derived stem cells (BMSCs) ameliorates renal function loss following cisplatin-induced acute kidney injury (AKI). The aim of this study was to explore whether the combination granulocyte-colony stimulating factor (G-CSF) and plerixafor (AMD3100) exerts beneficial effects on recovery in a model nephrotoxicity. Methods...